Sapient Capital »

Vaneck Vectors Pharmaceutical etf shares owned by Sapient Capital

Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by Sapient Capital from 13F filings

Historical chart of Sapient Capital investment in Vaneck Vectors Pharmaceutical etf

Tip: Access up to 7 years of quarterly data

All positions including Vaneck Vectors Pharmaceutical etf held by Sapient Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by Sapient Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $226k 2.6k 87.33
2025-06-30 $228k 2.6k 87.96
2025-03-31 $236k 2.6k 91.13

More positions owned by Sapient Capital

Eli Lilly & Co. (LLY)
Applovin Corp Com Cl A (APP)
Apple (AAPL)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Vistra Energy (VST)
JPMorgan Chase & Co. (JPM)
NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)
Amazon (AMZN)
Netflix (NFLX)
Costco Wholesale Corporation (COST)
Bank of America Corporation (BAC)
Spdr S&p 500 Etf Tr Tr Unit (SPY)

View all positions for Sapient Capital

Top funds holding Vaneck Vectors Pharmaceutical etf

Goldman Sachs Group
Healthcare Of Ontario Pension Plan Trust Fund
Morgan Stanley
Wells Fargo & Company
Clal Insurance Enterprises Holdings
J.Safra Asset Management
Avalon Trust
Jpmorgan Chase & Co
J. Goldman & Co
Miller Investment Management
Jane Street
Revere Asset Management
Adamsbrown Wealth Consultants
Bnp Paribas Arbitrage, Snc
Prime Capital Investment Advisors

View all funds holding Vaneck Vectors Pharmaceutical etf